Custom Poseida Therapeutics Solutions with Miltenyi & Thermo Fisher

Poseida Therapeutics and T&L Biotechnology Co., Ltd. are proud to announce their latest collaboration in the development of innovative cell and gene therapies. This partnership combines Poseida's cutting-edge gene editing technologies with T&L Biotechnology's expertise in Cell Therapy to create groundbreaking treatments for a wide range of diseases, One of the first products to emerge from this collaboration is a novel CAR-T cell therapy targeting solid tumors. By harnessing the power of the patient's own immune system, this therapy has shown promising results in preclinical studies, demonstrating potent antitumor activity, This joint effort brings together Poseida's expertise in gene editing and T&L Biotechnology's proficiency in cell therapy manufacturing, setting the stage for a new era in personalized medicine. With both companies committed to advancing the forefront of biotechnology, this collaboration holds great promise for the future of cancer treatment, As Poseida Therapeutics and T&L Biotechnology Co., Ltd. continue to work together, they aim to develop and commercialize transformative cell and gene therapies that will make a meaningful impact on patient lives. Stay tuned for more exciting product developments from this dynamic partnership